Amundi Asset Management US’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-6,400
Closed -$181K 1564
2020
Q4
$181K Hold
6,400
﹤0.01% 1402
2020
Q3
$161K Buy
+6,400
New +$161K ﹤0.01% 1388